A pharmacy key is supposed to open a door.
It is a small object with a plain purpose: turn the lock, enter the room, reach the shelf, obtain the thing that the body has been waiting for. In Cuba, the key has acquired a second function. It shows who is still allowed to stand between a patient and a bottle of medicine.
The government has now explained the terms under which private pharmacies may enter Cuban life. They may manage community pharmacies, sell medicines and health products, and operate under the new regulatory opening announced this summer. But they may not import medicine themselves. Every foreign purchase must pass through Medicuba, under the Ministry of Public Health, or Farmacuba, the state pharmaceutical industry’s importer. The state has opened the shop window while retaining the key to the storeroom. (EFE, https://efe.com/salud/2026-09-09/cuba-farmacias-privadas-demanda-medicamentos-salud/) (efe.com)
This is not a technical detail. It is the entire policy.
A private pharmacy without the ability to buy is not quite a pharmacy in the ordinary sense. It is a licensed endpoint of a supply chain controlled elsewhere. It may make a neighborhood counter cleaner, more responsive, better stocked at moments. It may offer a legal channel where improvisation has ruled. But it cannot choose the route, negotiate the shipment, build the supplier relationship, move money independently or decide when scarcity has become too expensive to tolerate. Its independence stops at the border.
Cuba knows this architecture well. The revolution has always preferred the appearance of distribution to the risks of autonomy. It permits a door, then keeps the corridor. It authorizes an enterprise, then reserves the lever that makes enterprise possible. The system does not merely regulate commerce. Every modern state regulates medicines. The Cuban state regulates the conditions under which regulation itself can become a monopoly.
The government’s strongest case deserves to be taken seriously. Medicines are not sneakers or imported kitchen appliances. They require cold chains, trained pharmacists, traceable lots, reliable storage, quality controls and a credible authority capable of removing dangerous products before they reach a sick person. A country suffering fuel shortages, weak transport and counterfeit risk cannot sensibly treat antibiotics and insulin as ordinary consumer goods. The new rules require licensed premises, qualified professional oversight and Cuban sanitary registration; they also exclude hospital-only and controlled medicines from private sale. Those are not irrational safeguards. (EFE, https://efe.com/salud/2026-09-09/cuba-farmacias-privadas-demanda-medicamentos-salud/; Granma, https://www.granma.cu/cuba/2026-07-29/flexibilizan-el-ejercicio-de-actividades-para-los-actores-economicos-no-estatales-28-07-2026-20-07-45) (efe.com)
But a safeguard can become a gatehouse.
The question is not whether Cuba needs pharmaceutical rules. It plainly does. The question is whether the state institutions now designated as indispensable intermediaries can perform the work they are claiming for themselves. That is harder. The same system promising to accompany private pharmacies through supplier selection, import procedures, warehousing and transport is the system whose public pharmacies have become shorthand for absence. EFE reports that Cuba’s basic medicine list contains 651 items, and that the government says it has been unable to obtain 69 percent of them. That figure is a claim from the Cuban side of a sanctions dispute, not an independently audited inventory. Yet no Cuban needs an audit to understand the more basic fact: a prescription is not treatment when the shelf is empty. (EFE, https://efe.com/salud/2026-09-09/cuba-farmacias-privadas-demanda-medicamentos-salud/) (efe.com)
The historical irony is almost too neat. For decades, Havana defended the state monopoly over health as one of the Revolution’s moral achievements. Medicine would not be left to private profit. Care would be universal. The pharmacy would be an extension of a social compact rather than a cash register.
Now the state is inviting private capital into that sacred room because it cannot adequately stock it alone. Yet it still cannot bear to surrender the commanding position. The private pharmacist may stand behind the counter. The state importer remains behind the pharmacist.
This is why the announcement feels less like a transition than a carefully managed confession. The regime has conceded that the old model cannot supply the country. It has not conceded that Cubans should be free to solve the problem without being routed through official channels. The correction is designed to preserve the principle that created the failure: no essential relationship with the outside world should exist unless the state can inspect, tax, delay and, when necessary, deny it.
There are 36 pharmaceutical projects under review, according to the health authorities cited by EFE. Three are being formed; fourteen have received approval to continue their paperwork. Not one private pharmacy has officially opened to the public. The numbers are modest, but their order matters. Cuba has not yet created a functioning alternative. It has created a queue for permission to create one. (efe.com)
The regime will say that this is prudence. It will say that pharmaceuticals cannot be liberalized recklessly in a sanctioned, cash-starved island where supply is fragile and public health is too important to gamble with. Again, there is truth inside the argument. A medicine market organized solely by purchasing power would be cruel in a country where wages and hard currency already divide life into separate realities. The state network, with its subsidies, should not simply be abandoned to make room for boutiques selling survival at market rates.
But that is not the choice. Cuba need not choose between a public pharmacy that has little to dispense and a private one permitted to sell anything at any price. It could build transparent licensing, permit qualified importers, publish inventories, enforce quality standards, protect vulnerable patients and allow competition where competition improves supply. It could separate safety oversight from commercial command. It could stop treating every independent supply line as a political threat.
That would require trust in citizens, and trust is the commodity the Cuban system has never learned to produce.
The opening of 2015 through 2017 briefly suggested a different logic. Cuba did not become free. Its coercive machinery remained intact. But more people could imagine a country connected by ordinary transactions rather than exceptional permissions: family visits, small businesses, travel, trade, conversation. That window has closed. It cannot be reconstructed by reopening one sector at a time while preserving the habits that make every opening provisional.
A pharmacy is not a revolution. It is not even a health system.
It is a room where a person arrives with a need, presents a paper, pays what can be paid, and leaves with something that might help. The state has now permitted another person to run that room.
But it has kept the key.
Natalia Suyos writes for Cuba Journal on Business.
